156 related articles for article (PubMed ID: 37829808)
1. Benefits of basil tea for patients with differentiated thyroid cancer during radioiodine therapy: A randomized controlled trial.
Nomura K; Nakayama M; Okizaki A
Heliyon; 2023 Oct; 9(10):e20691. PubMed ID: 37829808
[TBL] [Abstract][Full Text] [Related]
2. Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer.
Nomura K; Nakayama M; Okizaki A
Ann Nucl Med; 2023 Aug; 37(8):462-469. PubMed ID: 37149836
[TBL] [Abstract][Full Text] [Related]
3. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma.
Shi ZY; Zhang SX; Fan D; Li CH; Cheng ZH; Xue Y; Wu LX; Lu KY; Yang SY; Cheng Y; Wu ZF; Gao C; Li XF; Liu HY; Li SJ
Front Immunol; 2022; 13():901263. PubMed ID: 35844520
[TBL] [Abstract][Full Text] [Related]
5. Seeking Optimal Management for Radioactive Iodine Therapy-induced Adverse Effects.
Charalambous A
Asia Pac J Oncol Nurs; 2017; 4(4):319-322. PubMed ID: 28966960
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound Changes in Salivary Glands after Radioactive Iodine Treatment in Benign Diseases and Differentiated Cancer of Thyroid Glands in Consideration of Dose and Time Dependency.
Koch M; Fauck V; Sievert M; Mantsopoulos K; Iro H; Mueller S
Ultraschall Med; 2024 Jan; ():. PubMed ID: 38171382
[TBL] [Abstract][Full Text] [Related]
7. Combined BRAF
Campennì A; Ruggeri RM; Siracusa M; Pignata SA; Di Mauro F; Vento A; Trimarchi F; Baldari S
J Endocrinol Invest; 2018 Nov; 41(11):1283-1288. PubMed ID: 29549631
[TBL] [Abstract][Full Text] [Related]
8. Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies.
Hartung-Knemeyer V; Nagarajah J; Jentzen W; Ruhlmann M; Freudenberg LS; Stahl AR; Bockisch A; Rosenbaum-Krumme SJ
Ann Nucl Med; 2012 Nov; 26(9):723-9. PubMed ID: 22802008
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy.
Jafari E; Alavi M; Zal F
Radiat Environ Biophys; 2018 Aug; 57(3):233-240. PubMed ID: 29860661
[TBL] [Abstract][Full Text] [Related]
10. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
Claimon A; Pusuwan P; Khiewvan B
J Med Assoc Thai; 2017 Feb; 100(2):207-18. PubMed ID: 29916638
[TBL] [Abstract][Full Text] [Related]
11. Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases.
Yang J; Zheng R; Liang M; Jia Y; Lin L; Geng J; Chen S; Li YX
Front Oncol; 2019; 9():558. PubMed ID: 31316914
[No Abstract] [Full Text] [Related]
12. To Use or Not to Use 131I in Thyroid Cancer.
Metter D; Phillips WT; Walker RC; Blumhardt R
Clin Nucl Med; 2018 Sep; 43(9):670-671. PubMed ID: 30080184
[TBL] [Abstract][Full Text] [Related]
13. Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients.
Campennì A; Ruggeri RM; Siracusa M; Comis AD; Romano D; Vento A; Lanzafame H; Capoccetti F; Alibrandi A; Baldari S; Giovanella L
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2466-2475. PubMed ID: 33416957
[TBL] [Abstract][Full Text] [Related]
14. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer.
Kim HO; Lee K; Lee SM; Seo GH
JAMA Intern Med; 2020 Jan; 180(1):54-61. PubMed ID: 31633736
[TBL] [Abstract][Full Text] [Related]
15. Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer.
Simões-Pereira J; Mourinho N; Ferreira TC; Limbert E; Cavaco BM; Leite V
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3911-e3922. PubMed ID: 34134139
[TBL] [Abstract][Full Text] [Related]
16. Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer.
Sun Y; Sun Q; Tian J; He X
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1413-e1423. PubMed ID: 37167097
[TBL] [Abstract][Full Text] [Related]
17. Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of
Pan M; Li Z; Jia M; Lu X
Front Endocrinol (Lausanne); 2022; 13():857057. PubMed ID: 35464061
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial investigating the effects of an
Lopresti AL; Smith SJ; Metse AP; Drummond PD
Front Nutr; 2022; 9():965130. PubMed ID: 36185698
[TBL] [Abstract][Full Text] [Related]
19. European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.
Luster M; Aktolun C; Amendoeira I; Barczyński M; Bible KC; Duntas LH; Elisei R; Handkiewicz-Junak D; Hoffmann M; Jarząb B; Leenhardt L; Musholt TJ; Newbold K; Nixon IJ; Smit J; Sobrinho-Simões M; Sosa JA; Tuttle RM; Verburg FA; Wartofsky L; Führer D
Thyroid; 2019 Jan; 29(1):7-26. PubMed ID: 30484394
[TBL] [Abstract][Full Text] [Related]
20. Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
Tian T; Qi Z; Huang S; Wang H; Huang R
J Clin Endocrinol Metab; 2023 Jul; 108(8):2033-2041. PubMed ID: 36715264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
